(19)
(11) EP 4 824 067 A1

(12)

(43) Date of publication:
21.10.2026 Bulletin 2026/43

(21) Application number: 26715812.9

(22) Date of filing: 13.02.2026
(51) International Patent Classification (IPC): 
C07D 489/12(2006.01)
G01N 33/53(2006.01)
C07K 7/06(2006.01)
C07K 17/06(2006.01)
A61K 31/485(2006.01)
C07K 4/00(2006.01)
C07K 9/00(2006.01)
G01N 33/58(2006.01)
(52) Cooperative Patent Classification (CPC):
G01N 33/5308; C07D 489/02; C07H 15/203; C07K 16/44; C07K 2317/92; C07K 2317/33; C07K 16/16; C07H 17/02; G01N 33/9486; G01N 2440/38; G01N 2400/02; G01N 33/9473; G01N 2400/00; G01N 33/94; G01N 33/948
(86) International application number:
PCT/US2026/015345
(87) International publication number:
WO 2026/177981 (27.08.2026 Gazette 2026/35)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH LA MA MD TN

(30) Priority: 20.02.2025 US 202563761006 P

(71) Applicant: ARK Diagnostics, Inc.
Fremont, CA 94538 (US)

(72) Inventors:
  • SINGH, Rajendra
    San Jose, California 95135 (US)
  • OH, Soon Jin
    Sunnyvale, California 94085 (US)
  • LIANG, Jie
    Newark, California 94560 (US)

(74) Representative: Mewburn Ellis LLP 
Aurora Building Counterslip
Bristol BS1 6BX
Bristol BS1 6BX (GB)

   


(54) IMMUNOASSAYS FOR BUPRENORPHINE AND METABOLITES